SEOM guidelines for endometrial cancer

Clinical and Translational Oncology

Volumn 14, Issue 7, 2012, Pages 512-515

  Oaknin, Ana ^a   Rodríguez Freixinós, Víctor ^a   Díaz De Corcuera, Isabela ^b   Rivera, Fernando ^c   Del Campo, José María ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL DE GALDAKAO   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Adjuvant treatment; Endometrial cancer; Stage

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; PACLITAXEL;

ABDOMINAL RADIOTHERAPY; ADJUVANT THERAPY; ADVANCED CANCER; ARTICLE; BONE MARROW SUPPRESSION; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE FREE SURVIVAL; DRUG EFFICACY; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MEDICAL SOCIETY; MOLECULAR DIAGNOSIS; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NEUROPATHY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RISK REDUCTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT RESPONSE;

CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MEDICAL ONCOLOGY; NEOPLASM METASTASIS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RECURRENCE; SOCIETIES, MEDICAL; SPAIN;

EID: 84864714210     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0833-z     Document Type: Article

References (17)

1. Jemal A, Siegel R, Xu J et al (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300
2. Ellenson LH, Ronnett BM, Soslow RA et al (2011) Endometrial carcinoma. In: Kurman RJ, Ellenson lH, Ronnett BM (eds) Blaustein's pathology of the female genital tract, 6th edn. Springer, Berlin, pp 393-452
3. Pecorelli S (2009) Revised FIGO staging for carcinomaof the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103-104
4. ASTEC/EN.5 Study Group. Blake P, Swart AM, Orton J et al (2009) Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 373:137-146
5. Nout RA, Smit VT, Putter H et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of highintermediate risk (PORTEC-2): an open-label, noninferiority, randomised trial. Lancet 375:816-823
6. Kitchener H, Swart AM, Qian Q et al (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 373:125-136
7. Benedetti Panici P, Basile S, Maneschi F et al (2008) Systemic pelvic lymphadenectomy vs no lymphadenectomy in early stage endometrial carcinoma: randomized clinical trial. J Natl CancerInst 100:1707-1716
8. Creutzberg C, van Putten Wl, Koper P et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 ndometrial carcinoma: multicentre randomized trial. Lancet 355:1404-1411
9. Keys HM, Roberts JA, Brunetto Vl et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecolgic Oncology Group study. Gynecol Oncol 92:744-751
10. Maggi R, Lissoni A, Spina A et al (2006) Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomized trial. Br J Cancer 95:266-271
11. Susumu N, Sagae S, Udagawa Y et al (2008) Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 108:226-233
12. Hogberg T, Signorelli M, de Oliveira CF et al 2010) Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer. Results from two randomized studies. Eur J Cancer 46:2422-2431
13. Greven K, Winter K, Underhill K et al (2006) Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 103:155-159
14. Randall ME, Filiaci Vl, Muss H et al (2006) Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 24:36-44
15. Thigpen JT, Brady MF, Homesley HD et al (2004) Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 22:3902-3908
16. Fleming GF, Brunnetto Vl, Cella D et al (2004) Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgastrim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 22:2159-2166
17. Thigpen JT, Brady MF, Alvarez RD et al (1999) Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 17:1736-1744